Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Navid Paydari"'
Autor:
Mahshid Givi, Nizal Sarrafzadegan, Mohammad Garakyaraghi, Ghasem Yadegarfar, Masoumeh Sadeghi, Alireza Khosravi, Amir Hossein Azhari, Mohammad Reza Samienasab, Davood Shafie, Mohammad Saadatnia, Hamidreza Roohafza, Navid Paydari, Azam Soleimani, Mohsen Hosseinzadeh, Seyed Abdullah Ahmadi, Leila Dehghani, Jamshid Najafian, Elham Andalib, Javad Shahabi, Mohammad Reza Sabri
Publikováno v:
ARYA Atherosclerosis, Vol 13, Iss 5, Pp 236-244 (2017)
BACKGROUND: Our aim was to create and establish a database called “Persian Registry Of cardioVascular diseasE (PROVE)” in order to be used for future research and in addition, as a tool to develop national guidelines for diagnosis, treatment, and
Externí odkaz:
https://doaj.org/article/d726e95f4b974291b8bf5d3e95902dd7
Autor:
Ali Reza Khosravi, Mohamadhosein Hoseinabadi, Masoud Pourmoghaddas, Shahin Shirani, Navid Paydari, Mahmoud Sadeghi, Soheila Kanani, Mahnaz Jozan, Elham Khosravi
Publikováno v:
ARYA Atherosclerosis, Vol 9, Iss 1, Pp 38-44 (2013)
BACKGROUND: Primary percutaneous coronary intervention (PPCI) is considered as a choice of treatment in ST-elevation myocardial infarction (STEMI). PPCI has been performed in the Isfahan Province for several years. This study was performed to describ
Externí odkaz:
https://doaj.org/article/35a4386d143f41209456d82d325bd740
Autor:
Navid Paydari, Seyed Kianoosh Hosseini, Alireza Amirzadegan, Gholamreza Davoodi, Ali Abbasi, Saeed Sadeghian, Mojtaba Salarifar, Aida Biria, Parisa Moemeni
Publikováno v:
Journal of Tehran University Heart Center, Vol 4, Iss 1, Pp 29-34 (2009)
Background: We sought to evaluate the efficacy and safety of the different trade forms of streptokinase available in our country, namely Heberkinasa (Heberbiotec, Havana, Cuba) and Streptase (Aventis Behring GmbH, Marburg, Germany). Methods: We condu
Externí odkaz:
https://doaj.org/article/13c5504b649e41a29c2c35f90c8076c2
Autor:
Navid Paydari, Hamidreza Poorhoseini, Davood Kazemi Saleh, Alimohammad Haji Zeinali, Mohammad Alidoosti, Mojtaba Salarifar, Mohammad Sahebjam, Seyed Ebrahim Kassaian, Gholamreza Davoodi, Mehran Mahmoodian, Seyed Hesameddin Abbasi
Publikováno v:
Journal of Tehran University Heart Center, Vol 1, Iss 3, Pp 155-161 (2006)
Background: This study sought to access differences in long-term (9 months) outcomes between Acute Coronary Syndrome (ACS) patients who undergo early intervention compared to Percutaneous Coronary Intervention (PCI) in stable and refractory condition
Externí odkaz:
https://doaj.org/article/8bd0e9fa619e42639ae08b808b8003fb
Autor:
Kyomars Abbasi, Mojtaba Salarifar, Saeed Sadeghian, Hosein Ahmadi, Abbassali Karimi, Hakimeh Sadeghian, Navid Paydari, Mohammad Majd
Publikováno v:
Journal of Tehran University Heart Center, Vol 1, Iss 1, Pp 18-21 (2006)
Background: In cases of moderate(2 or 3+ on a scale of 0 to 4+) nonorganic mitral regurgitation (MR) and coronary artery disease, operative strategy continues to be debated between coronary artery bypass grafting alone (CABG) or concomitant valve rep
Externí odkaz:
https://doaj.org/article/944578aacfbb4fd990c9114c60f903dd
Autor:
Mojtaba Salarifar, Saeed Sadeghian, Ali Abbasi, Gholamreza Davoodi, Alireza Amirzadegan, Seyed Kianoosh Hosseini, Navid Paydari, Aida Biria, Parisa Moemeni
Publikováno v:
Journal of Tehran University Heart Center, Vol 4, Iss 1 (2009)
Background: We sought to evaluate the efficacy and safety of the different trade forms of streptokinase available in our country, namely Heberkinasa (Heberbiotec, Havana, Cuba) and Streptase (Aventis Behring GmbH, Marburg, Germany). Methods: We cond
Externí odkaz:
https://doaj.org/article/c234fc9098b54741ad4fa4f5b9ca6d06
Autor:
Seyed Ebrahim Kassaian, Mohammad Sahebjam, Mojtaba Salarifar, Mohammad Alidoosti, Alimohammad Haji Zeinali, Davood Kazemi Saleh, Hamidreza Poorhoseini, Navid Paydari, Gholamreza Davoodi, Mehran Mahmoodian, Seyed Hesameddin Abbasi
Publikováno v:
Journal of Tehran University Heart Center, Vol 1, Iss 3 (2006)
Background: This study sought to access differences in long-term (9 months) outcomes between Acute Coronary Syndrome (ACS) patients who undergo early intervention compared to Percutaneous Coronary Intervention (PCI) in stable and refractory condition
Externí odkaz:
https://doaj.org/article/d6c69d89c03c41a4b0cdd0b25d91d2be
Autor:
Hakimeh Sadeghian, Abbassali Karimi, Hosein Ahmadi, Mojtaba Salarifar, Saeed Sadeghian, Nader Fallah, Navid Paydari, Mohammad Majd
Publikováno v:
Journal of Tehran University Heart Center, Vol 1, Iss 1 (2006)
Background: In cases of moderate(2 or 3+ on a scale of 0 to 4+) nonorganic mitral regurgitation (MR) and coronary artery disease, operative strategy continues to be debated between coronary artery bypass grafting alone (CABG) or concomitant valve rep
Externí odkaz:
https://doaj.org/article/e6b385274d59441ab91ea48fd2b7d7aa
Autor:
Asieh Mansouri, Fatemeh Nouri, Toba Kazemi, Alireza Khosravi, Ahmadreza Assareh, Farzad Shahsanayi, Hossein Farshidi, Nizal Sarrafzadegan, Ebrahim Nematipour, Arsalan Khaledifar, Kiyan Heshmat-Ghahdarijani, Navid Paydari, Marjan Mansourian, Mohammad Mehdi Peighambari, Mohammad Behnammoghadam, Feridoun Noohi, Marzieh Taheri
Publikováno v:
Current Problems in Cardiology. 46:100577
We aimed to present the methodology of a national registry entitled “Persian CardioVascular Disease Registry (PCVDR).” Persian Registry Of cardioVascular diseasE (PROVE) was a demonstration registry conducted in Isfahan since 2014 to test the fea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d19e273f45d19d4165ab77b2212a442
https://doi.org/10.1016/j.cpcardiol.2020.100577
https://doi.org/10.1016/j.cpcardiol.2020.100577
Autor:
M. Raissi Dehkordi, Hamidreza Poorhosseini, Mehran Mahmoodian, Mojtaba Salarifar, D. Kazemisaleh, A.V. Farahani, Seyed Ebrahim Kassaian, Alimohammad Hajizeinali, Ebrahim Nematipour, Ahmad Sharafi, Mohammad Alidoosti, Navid Paydari
Publikováno v:
Cardiovascular Journal of Africa
Introduction : We investigated the outcomes of stenting with overlapping drug-eluting stents (DES) versus overlapping stenting with a combination of drug-eluting and bare metal stents (BMS) in very long coronary lesions (≥ 25 mm). Methods and Resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7033f9e9d999fca7645d8db94e0b6010
https://doi.org/10.5830/cvja-2010-004
https://doi.org/10.5830/cvja-2010-004